
Benefits of Point-of-Care Testing in Community Pharmacy Practice
A panelist discusses how implementing point-of-care testing in community pharmacies can be a significant revenue driver while creating a destination point for patients to receive health care services, especially in areas with limited access to providers.
Episodes in this series

Introduction and Value Proposition
Main Discussion Topics:
- Point-of-care testing as a revenue driver for community pharmacies
- Addressing health care deserts through accessible pharmacy services
- Strengthening provider relationships through complementary care
Key Points for Physicians:
- Point-of-care testing in pharmacies can complement physician care
- Services include COVID-19, influenza, streptococcal infection, hemoglobin A1c, and cholesterol testing
- Pharmacies see patients approximately 33 times annually vs 3 physician visits
Notable Insights:
- Independent consultant Deloitte predicts point-of-care testing will exceed immunizations as a revenue driver in community pharmacies
- Revenue comparison: one $90 point-of-care test equals profit from approximately 90 prescriptions
- Approximately 52% of the population lacks adequate access to health care
Clinical Significance:
Point-of-care testing in pharmacies represents a transformational opportunity to extend health care access, improve patient outcomes, and create sustainable clinical service revenue while strengthening collaborative care models between pharmacists and physicians.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.



















































































































































